Immunochem
Company

Immunochem

Biotechnology Research Be 4 employees
Employees
4
Contacts
1
Emails
1

Immunochem Overview

Headquarters
Be
Industry
Biotechnology Research
Employees
4
Founded
1998
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Immunochem

Create your single-domain antibody in 6 weeks effortlessly with our unique EVOBodies™ program. This is our promise. At IMMUNOCHEM we believe that you shouldn’t struggle to generate antigen-binding molecules as starting materials for your crucial research. Through the EVOBodies™ platform, IMMUNOCHEM provides precise AI-driven antibody discovery, helping bio-pharmaceutical managers and scientists : 👉 save time 👉 reduce stress 👉 achieve the groundbreaking research results they deserve. Today, by combining AI and biological tools, you have the power in your hand to create your tailored antibodies in only a few weeks. Rather than waiting months for unpredictable results from traditional immunization processes. What's even better? This method works for any antigen, including : 🎯 little or non-immunogenic 🎯 toxic for the host 🎯 highly conserved 🎯 targeting vital functions 💫 Follow our Linkedin page and let's embark on this groundbreaking adventure together.

Immunochem Contact Details

People in AeroLeads
2
With contact data
1
Email contacts
1
50.0% coverage

Immunochem Org Chart

Sample employees and titles
Name Title Contact
Grant Armstrong Computational Nanobody Design - M.s. in Data Science
Email
Maria Belen Rombola Caldentey Research Scientist Transforming Science Into Solutions: Bridging Biotechnology and Innovation - Molecular and Cell Biology - Research and Development
View

Immunochem Tech Stack

Data / AI 2 profiles

Compare Similar Companies to Immunochem